Evidence-Based Complementary and Alternative Medicine

Traditional Chinese Medicine for Digestive System Tumors


Publishing date
01 Dec 2022
Status
Published
Submission deadline
12 Aug 2022

Lead Editor

1First Affiliated Hospital of Hebei North University, Zhangjiakou, China

2Sun Yat-sen University, Guangzhou, China

3University of California, San Francisco, USA


Traditional Chinese Medicine for Digestive System Tumors

Description

Digestive system tumors, including esophageal cancer, gastric cancer, and colorectal cancer, are among the most common cancer types in the world and are the cause of much cancer-related mortality in the world. They are a major threat to human health and are usually diagnosed at an advanced stage. A large number of studies have investigated the use of traditional Chinese medicine (TCM) as an adjuvant therapy in the treatment of digestive system tumors. This TCM has been suggested to possess great advantages in terms of suppressing tumor progression, increasing the sensitivity of chemo-, radio-, or targeted therapeutics, improving an organism's immune system function, and lessening the damage caused by these therapeutics.

In recent years, anti-tumor preparation of TCM has become a hot spot in the research and development of new drugs. Before components and compounds derived from TCM can enter clinical trials of new drugs, there must be research into their pharmacodynamics and safety and evidence to support their preclinical effectiveness. In order to improve the medicinal properties of these TCM drugs, it is urgent to strengthen research on the correlation between their antitumor activity and cytotoxic effect in the digestive system. There also needs to be research directed towards new drug delivery technologies, methods, and advantages of improving oral absorption, changing distribution in vivo, and increasing targeting and improving percutaneous and mucosal absorption of TCM active ingredients. Intestinal flora is a complex microecosystem in the human body, known as the second genome of the human body. TCM can play an anti-tumor role by regulating intestinal flora in coordination with anti-cancer drugs, increasing body immunity, inhibiting the expression of inflammatory factors, and promoting the activity of probiotics.

The aim of this Special Issue is to collect original and review articles on basic and clinical research discussing TCM and natural products for gastrointestinal tract cancer prevention and therapy. We especially welcome applications of TCM and natural products in enhancing chemotherapy and immunotherapy.

Potential topics include but are not limited to the following:

  • Isolation and characterization of natural products with anti-digestive system tumor activity
  • Chemical properties, structure identification, and synthetic routes of natural and herbal extracts
  • Toxicological effects of natural and herbal extracts with anti-digestive system tumor activity
  • Biological and pharmacological activities of natural and herbal extracts in the prevention and treatment of digestive system tumors.
  • Research on the medicinal properties of natural and herbal extracts, including efficacy, safety, pharmacokinetics, absorption, distribution, and excretion pathways in vivo
  • Synergistic effect of drugs and natural products on digestive system tumors
  • Preclinical and clinical trials of natural and herbal extracts for the treatment of digestive system tumors
  • Bioinformatics analysis of natural and herbal extracts for the treatment of digestive system tumors
  • The effect of intestinal flora on tumors and the regulating effect of Chinese medicine on intestinal flora
  • Effects of intestinal flora on tumor immunity and the effects of the intervention of TCM

Articles

  • Special Issue
  • - Volume 2023
  • - Article ID 9898150
  • - Retraction

Retracted: Noncoding RNAs and Virus and Treatment in Allergic Rhinitis

Evidence-Based Complementary and Alternative Medicine
  • Special Issue
  • - Volume 2023
  • - Article ID 9762457
  • - Retraction

Retracted: Heparin-Binding Protein Aggravates Acute Lung Injury in Septic Rats by Promoting Macrophage M1 Polarization and NF-κB Signaling Pathway Activation

Evidence-Based Complementary and Alternative Medicine
  • Special Issue
  • - Volume 2023
  • - Article ID 4946642
  • - Review Article

Meta-Analysis of Capecitabine versus 5-Fluorouracil in Advanced Gastric Cancer

Zhongliang Wu | Xingfa Zhang | ... | Yi Lin
  • Special Issue
  • - Volume 2023
  • - Article ID 9402155
  • - Research Article

Nourishing Kidney Promoting Ovulation Decoction (NKPOD) Attenuates Polycystic Ovary Syndrome by Downregulating miRNA-224

Yinhua Guo | Xingli Tong | ... | Yong Tan
  • Special Issue
  • - Volume 2023
  • - Article ID 2919811
  • - Research Article

Naringin Prevents Cognitive Dysfunction in Aging Rats by Inhibiting Toll-Like Receptor 4 (TLR4)/NF-κB Pathway and Endoplasmic Reticulum Stress

Xiao-jie Dai | Yi Jia | ... | Mei-ning Zhou
  • Special Issue
  • - Volume 2023
  • - Article ID 5628551
  • - Research Article

Role of Laryngopharyngeal Reflux Changes in Children with Adenoid Hypertrophy: A Randomized Controlled Prospective Study

Yu Zhou | Ruixia Ma | ... | Pei Yang
  • Special Issue
  • - Volume 2023
  • - Article ID 9731315
  • - Review Article

Clinical Evidence and Potential Mechanisms in Treating Radiation Enteritis with Modified Baitouweng Decoction

Zihong Wu | Bei Yin | ... | Fengming You
  • Special Issue
  • - Volume 2022
  • - Article ID 5689900
  • - Research Article

[Retracted] Efficacy of Periodontal Endodontics Combined with Diode Laser (DL) Therapy on Severe Periodontitis

Sijia Liu | Xu Zhang | Quanying Zhou
  • Special Issue
  • - Volume 2022
  • - Article ID 1533346
  • - Research Article

[Retracted] A Three-Year Prospective Study Assessing the Application of Chromosomal Microarray Analysis in 576 High-Risk Pregnant Women

Minmin Jiang | Shengwen Huang | ... | Keyan Linghu
  • Special Issue
  • - Volume 2022
  • - Article ID 1979447
  • - Research Article

[Retracted] Noncoding RNAs and Virus and Treatment in Allergic Rhinitis

Zhu Lei | Guangrui Feng | ... | Zhifeng Ning

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.